Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. is projected to experience a steady growth trajectory, with an expected normalized Funds From Operations per share (FFOps) growth of 6.7% in 2025 and 7.9% annual growth projected over the next five years. A favorable environment for rent increases upon upcoming lease expirations is anticipated to act as a positive catalyst, particularly in the skilled nursing segment, enhancing revenue generation. Despite mixed performance in the third quarter senior housing operating portfolio, underlying fundamentals remain solid, supported by a promising pipeline of accretive investment opportunities.

Bears say

National Health Investors Inc. faces a negative outlook primarily due to concerns surrounding potential lower-than-anticipated rent resets from NHC, which could significantly impact earnings. Additionally, the company's financial stability may be jeopardized if deferred rent collections weaken or if operators encounter challenges, particularly in the context of potential health crises. The downward adjustment of funds from operations (FFO) estimates for 2026 reflects a more conservative assessment of net investments, contributing to an overall less favorable financial forecast for the company.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.